Eisai Co (Eisai Co) Research & Development : $1,160 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Eisai Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Eisai Co's Research & Development for the three months ended in Mar. 2024 was $297 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $1,160 Mil.

Eisai Co Research & Development Historical Data

The historical data trend for Eisai Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Research & Development Chart

Eisai Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Research & Development

Get a 7-Day Free Trial

1,301.38

1,382.89

1,448.32

1,294.28

1,128.17

Eisai Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															386.01	291.08	281.57	289.61	297.34

Eisai Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,160 Mil.

Eisai Co (OTCPK:ESAIY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Eisai Co Research & Development Related Terms

Thank you for viewing the detailed overview of Eisai Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (Eisai Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESAIY) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

ESALF:USA 4523:Japan EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.